Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level (Q34575066)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level |
scientific article |
Statements
1 reference
Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level (English)
1 reference
Kenji Katsuno
1 reference
Yoshikazu Fujimori
1 reference
Yukiko Takemura
1 reference
Masahiro Hiratochi
1 reference
Fumiaki Itoh
1 reference
Yoshimitsu Komatsu
1 reference
Hideki Fujikura
1 reference
Masayuki Isaji
1 reference
18 October 2006
1 reference
1 reference
Identifiers
1 reference